Mineralys Therapeutics, Inc.
Industry: Life Sciences ・ $MLYS on Nasdaq
Insider Sale
+$210,052
-1.7%
Shares
Shares Volume: 15,746 Shares
Average Share Price: $13.34
INSIDER
Congleton Jon
Chief Executive Officer (Director)
reported on Jul 12 2024
traded on Jul 11 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 911,212 |
| PURCHASES/SALES 1Y | 4 / 3 |
| P/S VALUE RATIO | 0.061 |
| AVERAGE SALE VALUE | $574,550.83 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 5 / 6 |
| P/S VALUE RATIO | 1.273 |
| AVERAGE SALE VALUE | $995,671.08 |
| COMPANY PREVIOUS TRADES |